Optimal immunosuppressive clinical regimen in liver transplantation

Transplant Proc. 1994 Oct;26(5):2676-8.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Acquired Immunodeficiency Syndrome / mortality
  • Adolescent
  • Adult
  • Antilymphocyte Serum / therapeutic use
  • Cause of Death
  • Cyclosporine / administration & dosage
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use
  • Drug Administration Schedule
  • Follow-Up Studies
  • Graft Rejection / epidemiology
  • Graft Rejection / therapy
  • Graft Survival*
  • Humans
  • Immunosuppression Therapy / methods*
  • Liver Diseases / surgery
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Retrospective Studies
  • Risk Factors
  • Survival Rate
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Muromonab-CD3
  • Cyclosporine
  • Methylprednisolone